sorafenib has been researched along with ag-490 in 1 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (ag-490) | Trials (ag-490) | Recent Studies (post-2010) (ag-490) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 732 | 2 | 322 |
| Protein | Taxonomy | sorafenib (IC50) | ag-490 (IC50) |
|---|---|---|---|
| Epidermal growth factor receptor | Homo sapiens (human) | 1.9224 | |
| Tyrosine-protein kinase JAK1 | Homo sapiens (human) | 3.38 | |
| large T antigen | Betapolyomavirus macacae | 14.61 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Cui, L; Feng, S; Guo, X; Li, B; Ning, G; Wang, T; Wang, X; Wang, Z; Xia, Z; Yu, M; Yuan, W; Yuan, X; Zhang, L; Zhang, Y; Zhang, Z | 1 |
1 other study(ies) available for sorafenib and ag-490
| Article | Year |
|---|---|
Sorafenib promotes sensory conduction function recovery via miR-142-3p/AC9/cAMP axis post dorsal column injury.
Topics: Adenylyl Cyclases; Animals; Cyclic AMP; Cyclic AMP Response Element-Binding Protein; Down-Regulation; Female; GAP-43 Protein; Guanosine Triphosphate; Interleukin-6; Isoquinolines; MicroRNAs; Phosphorylation; Rats; Recovery of Function; Rhodamines; RNA, Small Interfering; Sciatic Nerve; Sensation; Signal Transduction; Sorafenib; Spinal Cord Injuries; Sulfonamides; Tyrphostins; Up-Regulation | 2019 |